BSE filing, BSE: 543239. Summary written from the filing by ALFA Finder's alert engine.
G M Polyplast Ltd: key numbers
- Share price
- ₹63.00
- Market cap
- ₹84.80 Cr
- Revenue (annual)
- ₹103.0 Cr
- Net profit (annual)
- ₹8.27 Cr
- P/E (TTM)
- 10.3×Sector 52.0×
- Promoter holding
- 73.54%+0.00% QoQ
- FII holding
- 1.25%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from G M Polyplast Ltd
All →G M Polyplast Board Meeting Date
GM Polyplast will convene its board on 31 October 2026. The agenda includes approval of H1 FY27 standalone and consolidated un-audited results.
G M Polyplast Merger & Restructuring Worth ₹2 Cr
G M Polyplast Ltd received shareholder approval for the sale of machinery and spare parts to its wholly-owned subsidiary, Regranix Private Limited, for up to ₹2 Crore.
- Value
- ₹2.00 Cr
- Execution
- One year
G M Polyplast Management Change
G M Polyplast Limited has re-appointed Mr. Dinesh Balbeer Sharma as Managing Director and Chief Financial Officer. His tenure is effective from September 07, 2026.
G M Polyplast Annual General Meeting
G M Polyplast reported the outcome of its 23rd AGM held 7 September 2026. All ordinary and special resolutions, including borrowing powers and related-party dealings with Regranix, were approved.
G M Polyplast Board Meeting Outcome
G M Polyplast Limited announced the reconstitution of its Board Committees following the resignation of Independent Director Mr. Suhas Rane. This decision occurred at the board meeting.
G M Polyplast Annual General Meeting
G M Polyplast Limited has issued a notice for its 23rd Annual General Meeting scheduled for September 7, 2026. Key agenda items include related party transactions totaling ₹137 Crore.
- Value
- ₹137.0 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.